To access the full blog via Microsoft Sway, click here
Guideline News April 2024
Posted: Thursday, May 16, 2024
Category - Medicines Update
For all healthcare professionals across NHSGGC both in primary care and the acute sector.
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact medicines.update@ggc.scot.nhs.uk.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.
Posted: Thursday, May 16, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Thursday, May 16, 2024
Category - Medicines Update
Apixaban has replaced edoxaban as the preferred direct oral anticoagulant (DOAC) for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors (excluding mechanical valve replacement or moderate-severe mitral stenosis).
Posted: Thursday, May 16, 2024
Category - Medicines Update
An additional regulatory change in January 2024 for oral valproate medicines, means that:
Posted: Thursday, May 2, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Thursday, May 2, 2024
Category - Medicines Update
Includes:
Diazepam 10mg/2.5ml rectal solution tubes, Guanfacine (Intuniv®) 2mg and 3mg modified release tablets, Fiasp® (insulin aspart) FlexTouch 100units/ml solution for injection 3ml pre-filled pens, Levemir InnoLet® (insulin detemir) 100units/ml solution for injection pre-filled disposable devices, Insulatard InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices, Monomil® XL (isosorbide mononitrate) 60mg modified release tablets, Methadone 5mg tablets, Pabrinex® IV and IM injections, and Salbutamol 2.5mg/2.5ml nebules
Posted: Wednesday, May 1, 2024
Category - Medicines Update
Sitagliptin is now the preferred dipeptidylpeptidase-4 (DPP4) inhibitor in NHSGGC, replacing alogliptin.
Posted: Thursday, April 25, 2024
Category - Medicines Update
The NHSGGC Opioid Prescribing for Chronic Non Malignant Pain Guideline has been reviewed and updated.
Posted: Tuesday, April 16, 2024
Category - Medicines Update
To access the full blog via Microsoft Sway, click here
Posted: Monday, April 15, 2024
Category - Medicines Update
Guideline News March 2024 here
Posted: Monday, April 15, 2024
Category - Medicines Update
In January 2024, the MHRA issued an alert on regulatory action taken to update the indications for all systemic fluoroquinolones to state they should only be used when other commonly recommended antibiotics are inappropriate